AzTrials
AzTrials

LesbianLGBTNCT04256902

Lesbian, Gay, Bisexual, and Transgender (LGBT) Conference

An observational study of Lesbian and Gay, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Despite increased visibility and acceptance of the LGBT community (Lesbian, Gay, Bisexual and Transgender), in some parts of society, many LGBT people struggle with self-acceptance. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
Conditions the study is for
Lesbian, Gay, Bisexual
How many people
600 participants
Where
1 siteFrance
Study dates
20 Sep 2020to 20 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: all those registered for the conference and who agree to participate by answering the questionnaires

Who may be able to join

  • be registered for the LGBT conference

Who cannot join

  • Subject unable to read or/and write

Trial locations and contacts

1 site in 1 country.

France1 site
  • Uh Montpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Self-identification Based Intervention Targeting Sexual Orientation and Gender Identity

Despite increased visibility and acceptance of the LGBT community (Lesbian, Gay, Bisexual and Transgender), in some parts of society, many LGBT people struggle with self-acceptance. Minority Stress Theory, described in the scientific literature, explains that health disparities among populations such as the LGBT population can be explained by stressors induced by a hostile, homophobic culture, which results in harm suffered, expectations of rejection, and internalized homophobia. The harm suffered may include acts of discrimination, harassment, violence (physical or linguistic). But more deeply, two important points of this theory: 1) the expectations of the LGBT person to experience rejection based on their identity and the anti-LGBT social stigma, 2) internalized homophobia, which is a social internalization from negativity against homosexuality and transgender to the initial stages of the identity development of an individual who can continue throughout his life. Perceived harm, stigma and lived rejection are associated with an increased propensity to experience significant psychological pain. LGBT people are more likely to develop self-identification based on sexual orientation or gender, making them more vulnerable to any rejection signal.

There is a growing scientific interest around Cognitive and Behavioral Therapies (CBT) of 3rd wave, also called therapies derived from Buddhism, or therapies based on meditation. These programs aim to observe and test, through an experiential meta-cognitive practice, the dogmas or preconceptions (about ourselves, others, and the world) and mental attitudes that guide our choices without our knowledge and are at the origin of suffering, in order to gain inner freedom. These practices constitute an experiential scientific methodology of self-knowledge and reality. These secular programs have become a standard treatment in the management of stress, chronic pain, and the prevention of relapsing depression. In addition, the interest of these practices has been demonstrated in many areas of somatic and psychiatric medicine (including depression and suicidal behavior), but also for the promotion of mental health in the general population. This topic is the subject of more than 15,000 international scientific publications with reading committee (Medline indexed), and of strong interest and shared by both the scientific community and the general public.

Read more

Scientists are currently deepening these therapies with a focus on wisdom-based self-identification. Beyond the name "therapies", this educational information is key to life for everyone. Who am I ? Am I defined by my social roles, my physical characteristics, my preferences? How to face external challenges? How to develop real self-confidence?

Dr Déborah Ducasse offers a conference on the theme: "Sexual orientation, gender: where is the problem?" Nowhere. Self-identification. ". This conference will take place on 05/15/2020, on the occasion of World Day Against Homophobia.

In line with the OECD press release in 2019 "The LGBT challenge: how to improve the integration of sexual and gender minorities? "(Panorama de la société 2019: Social Indicators of the OECD), the investigators want to assess whether an intervention targeting valid self-identification can 1) have a positive impact on the acceptance and discrimination indicators of the OECD ; 2) have an impact on valid self-identification.

Direct benefits are expected, psychologically and socially, in the fight against discrimination, inclusion and self-acceptance.

In the medium and long term: major public health interest via the adaptation of psychoeducational interventions based on self-identification in order to prevent psychosocial risks and suicidal behavior in connection with an altered self-identification based on sexual orientation and gender.

Read the detailed description

A wide communication (media, social networks) will be organized around this conference which is free to enter A prior registration will be requested by email. For each person sending an email to register, they will be offered to participate in the research by following the web link to the Google Form questionnaire ("pre-conference") with information on the proposed research. Refusal to participate in the research will not prevent you from attending the conference, this will be mentioned when sending the link to the questionnaire.

At the end of the conference, another email will be sent to those who have agreed to participate with a new Google Form link to answer specific "post-conference" questions.

The impact of the conference will be studied by comparing the pre and post conference questionnaires

Main objective: Evaluate the impact of an educational intervention on self-identification (conference "Sexual orientation, gender: where is the problem? Nowhere. Self-identification." Lasting 2 hours), on the acceptance of homosexuality and transgender, in people coming to attend this intervention (evaluations before and after)

Secondary objectives: Evaluate the impact of an educational intervention on self-identification (2 hours), on the representations of stigmatization of homosexuality and transgender, in people coming to attend this intervention (evaluations before- after).

Keywords
self-identification, discrimination, mental health
Medical subject headings
Homosexuality, Female, Homosexuality, Bisexuality, Psychological Well-Being

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. acceptance of LGBT

    Criteria for assessing acceptance as mentioned in the 2019 OECD report

    Measured: 1 day

Secondary outcomes (1)
  1. stigmatisation of LGBT

    Criteria for assessing acceptance as mentioned in the 2019 OECD report

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2020
  2. Study start20 Sep 2020
  3. Primary completion1 May 2021
  4. Study completion20 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04256902
Sponsor's protocol ID
RECHMPL20_0069
Acronym
LGBT
Status last verified
Oct 2021
First submitted
3 Feb 2020
Last updated
19 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Lesbian and Gay, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

acceptance of LGBT (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in